Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

MGNX
MacroGenics, Inc.
stock NASDAQ

At Close
Dec 26, 2025 3:59:47 PM EST
1.62USD0.000%(0.00)443,946
0.00Bid   0.00Ask   0.00Spread
Pre-market
Dec 24, 2025 8:25:30 AM EST
1.59USD-1.846%(-0.03)0
After-hours
0.00USD0.000%(0.00)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
102.48M
CEO
Scott Koenig
Headquarters
Rockville, Maryland, USA
Industry
Biotechnology
Next Earnings
Feb 19, 2026 (53d)
Related
AMGNGILDBMYLLYPFEMRKSTMLXNCRXLV
MGNX Stats
Avg. Vol. 10 Day
2,496,152
Avg. Vol. 30 Day
1,811,700
Employees
330
Market Cap
102,478,822
Shares Out.
63,258,532
On/Off Exchange
44%/56%
6 Month Beta
1.70
1 Year Beta
1.72
2 Year Beta
1.57
3 Year Beta
1.50
52 Week Low
0.99
52 Week High
3.60
SMA50
1.54
SMA200
1.57
1 Week
+1.89%
1 Month
+5.88%
3 Month
-7.43%
6 Month
+36.13%
1 Year
-49.85%
2 Year
-83.70%
5 Year
-93.39%
Profile
a career at macrogenics could be waiting for you! please click on "careers" ---------------------------->>> to learn more. macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. macrogenics creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. the combination of macrogenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. these are exciting times at macrogenics and we hope that you will take the opportunity to learn more about our organization, our pipeline and to view our job opportunities!

MGNX Stock Summary

MacroGenics, Inc. (NASDAQ:MGNX) stock price today is $1.62, and today's volume is 443,946. MGNX is down 0.000% today. The 30 day average volume is 1,811,700. MGNX market cap is 102.48M with 63,258,532 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC